Global Constipation Market: Industry Analysis & Outlook (2017-2021)
Constipation is a chronic medical condition which makes a person unable to pass fecal content properly. In this condition, the stool is often dry, hard and painful to pass. Bowel movements vary person to person but, if the bowel movement is missing for more than 3 days in adults and 4 days in children, then it is considered as constipation. Constipation can be of three types; irritable bowel syndrome-constipation (IBS-C), chronic idiopathic constipation and opioid-induced-constipation (OIC).
The U.S. is a major contributor to the global constipation market supported by rising opioid usage among chronic disease patients and increasing prescription drugs volumes. The U.S. is likely to experience further growth in constipation market with increasing ageing population and rapid development of new drugs in the market.
There exist vast opportunities for prescription drugs in the constipation market. However, OTC drugs and laxatives are generally used for treating constipation, patients and physicians have started recognizing the importance of branded drugs. Future growth of the constipation market is based on continued growth of prescription therapies to treat constipation, increased research and development of novel drugs by biopharmaceutical companies, increasing patient and physician awareness of effective prescription alternatives to Over-the-Counter medications.
The global constipation market is expected to grow in future with rising constipation prevalence, increasing ageing population, rise in health expenditure, mounting spinal cord injury patient population, growing spending on medicines and pharmaceutical R&D expenditure. Key trends of this market include progressing drugs under pipeline and adoption of unhealthy lifestyle. However, there are some factors which can hinder growth of the market including stringent regulations and low awareness of prescription drugs.
The report “Global Constipation Market: Industry Analysis & Outlook (2017-2021)” by Koncept Analytics provides an extensive research and detailed analysis of the present market along with future outlook. The report discusses the major growth drivers and challenges of the market, covering the U.S., Japan, China and Europe. The report profiles the key players of the market including Ironwood Pharmaceuticals Inc., Sucampo Pharmaceuticals Inc., Synergy Pharmaceuticals Inc. and ARDELYX Inc.
The U.S. is a major contributor to the global constipation market supported by rising opioid usage among chronic disease patients and increasing prescription drugs volumes. The U.S. is likely to experience further growth in constipation market with increasing ageing population and rapid development of new drugs in the market.
There exist vast opportunities for prescription drugs in the constipation market. However, OTC drugs and laxatives are generally used for treating constipation, patients and physicians have started recognizing the importance of branded drugs. Future growth of the constipation market is based on continued growth of prescription therapies to treat constipation, increased research and development of novel drugs by biopharmaceutical companies, increasing patient and physician awareness of effective prescription alternatives to Over-the-Counter medications.
The global constipation market is expected to grow in future with rising constipation prevalence, increasing ageing population, rise in health expenditure, mounting spinal cord injury patient population, growing spending on medicines and pharmaceutical R&D expenditure. Key trends of this market include progressing drugs under pipeline and adoption of unhealthy lifestyle. However, there are some factors which can hinder growth of the market including stringent regulations and low awareness of prescription drugs.
The report “Global Constipation Market: Industry Analysis & Outlook (2017-2021)” by Koncept Analytics provides an extensive research and detailed analysis of the present market along with future outlook. The report discusses the major growth drivers and challenges of the market, covering the U.S., Japan, China and Europe. The report profiles the key players of the market including Ironwood Pharmaceuticals Inc., Sucampo Pharmaceuticals Inc., Synergy Pharmaceuticals Inc. and ARDELYX Inc.
1. OVERVIEW
1.1 Constipation
2. CONSTIPATION MARKET ANALYSIS
2.1 The U.S.
2.1.1 The U.S. Constipation Market by Value
2.1.2 The U.S. Constipation Market by Type
2.1.3 The U.S. Constipation Market Forecast by Value
2.1.4 The U.S. Constipation Market Forecast by Type
2.1.5 The U.S. Constipation Market by Drug
2.1.6 The U.S. Constipation Branded Drugs Prescription Volume
2.1.7 The U.S. Constipation Branded Drug Prescription Volume by Type
2.1.8 The U.S. Constipation Patient Population Forecast
2.2 Europe
2.2.1 Europe CIC Patient Population Forecast
2.2.2 Europe IBS-C Patient Population Forecast
2.2.3 Europe OIC Patient Population Forecast
2.2.4 Europe Plecanatide Sales Forecast
2.3 Japan
2.3.1 Japan Constipation Patient Population Forecast
2.3.2 Japan Amitiza Sales Forecast
2.4 China
2.4.1 China Constipation Patient Population Forecast
2.4.2 China Amitiza Sales Forecast
3. MARKET DYNAMICS
3.1 Growth Drivers
3.1.1 Rising Prevalence of Constipation
3.1.2 Increasing Ageing Population
3.1.3 Rising Healthcare Expenditure
3.1.4 Rising Spending on Medicines Worldwide
3.1.5 Rising Cases of Spinal Cord Injury
3.1.6 Increasing Pharmaceutical R&D Spending
3.2 Key Trends & Developments
3.2.1 Progressing Drugs Under Pipeline
3.2.2 Adoption of Unhealthy Lifestyle
3.3 Challenges
3.3.1 Stringent Regulations
3.3.2 Low Awareness of Prescription Constipation Drugs
4. COMPETITIVE LANDSCAPE
4.1 Global Market
4.1.1 Revenue Comparison of Key Players
4.1.2 Market Cap of Key Players
4.2 The U.S.
4.2.1 The U.S. Constipation Market Share by Company
4.2.2 The U.S. Constipation Market Share Forecast by Company
5. COMPANY PROFILES
5.1 Ironwood Pharmaceuticals Inc.
5.1.1 Business Overview
5.1.2 Financial Overview
5.1.3 Business Strategies
5.2 Sucampo Pharmaceuticals Inc.
5.2.1 Business Overview
5.2.2 Financial Overview
5.2.3 Business Strategies
5.3 ARDELYX, Inc.
5.3.1 Business Overview
5.3.2 Financial Overview
5.3.3 Business Strategies
5.4 Synergy Pharmaceuticals, Inc
5.4.1 Business Overview
5.4.2 Financial Overview
5.4.3 Business Strategies
1.1 Constipation
2. CONSTIPATION MARKET ANALYSIS
2.1 The U.S.
2.1.1 The U.S. Constipation Market by Value
2.1.2 The U.S. Constipation Market by Type
2.1.3 The U.S. Constipation Market Forecast by Value
2.1.4 The U.S. Constipation Market Forecast by Type
2.1.5 The U.S. Constipation Market by Drug
2.1.6 The U.S. Constipation Branded Drugs Prescription Volume
2.1.7 The U.S. Constipation Branded Drug Prescription Volume by Type
2.1.8 The U.S. Constipation Patient Population Forecast
2.2 Europe
2.2.1 Europe CIC Patient Population Forecast
2.2.2 Europe IBS-C Patient Population Forecast
2.2.3 Europe OIC Patient Population Forecast
2.2.4 Europe Plecanatide Sales Forecast
2.3 Japan
2.3.1 Japan Constipation Patient Population Forecast
2.3.2 Japan Amitiza Sales Forecast
2.4 China
2.4.1 China Constipation Patient Population Forecast
2.4.2 China Amitiza Sales Forecast
3. MARKET DYNAMICS
3.1 Growth Drivers
3.1.1 Rising Prevalence of Constipation
3.1.2 Increasing Ageing Population
3.1.3 Rising Healthcare Expenditure
3.1.4 Rising Spending on Medicines Worldwide
3.1.5 Rising Cases of Spinal Cord Injury
3.1.6 Increasing Pharmaceutical R&D Spending
3.2 Key Trends & Developments
3.2.1 Progressing Drugs Under Pipeline
3.2.2 Adoption of Unhealthy Lifestyle
3.3 Challenges
3.3.1 Stringent Regulations
3.3.2 Low Awareness of Prescription Constipation Drugs
4. COMPETITIVE LANDSCAPE
4.1 Global Market
4.1.1 Revenue Comparison of Key Players
4.1.2 Market Cap of Key Players
4.2 The U.S.
4.2.1 The U.S. Constipation Market Share by Company
4.2.2 The U.S. Constipation Market Share Forecast by Company
5. COMPANY PROFILES
5.1 Ironwood Pharmaceuticals Inc.
5.1.1 Business Overview
5.1.2 Financial Overview
5.1.3 Business Strategies
5.2 Sucampo Pharmaceuticals Inc.
5.2.1 Business Overview
5.2.2 Financial Overview
5.2.3 Business Strategies
5.3 ARDELYX, Inc.
5.3.1 Business Overview
5.3.2 Financial Overview
5.3.3 Business Strategies
5.4 Synergy Pharmaceuticals, Inc
5.4.1 Business Overview
5.4.2 Financial Overview
5.4.3 Business Strategies
LIST OF CHARTS
Types of Constipation
Current Treatment Options for Constipation
The U.S. Constipation Market by Value (2012-2016)
The U.S. Constipation Market by Type (2012-2016)
The U.S. Constipation Market Forecast by Value (2017-2021)
The U.S. Constipation Market Forecast by Type (2017-2021)
The U.S. Constipation Market by Drug (2016/2021)
The U.S. Constipation Branded Drugs Prescription Volume (2012-2016)
The U.S. Constipation Branded Drug Prescription Volume by Type (2012-2016)
The U.S. Constipation Patient Population Forecast (2016-2021)
Europe CIC Patient Population Forecast (2016-2021)
Europe IBS-C Patient Population Forecast (2016-2021)
Europe OIC Patient Population Forecast (2016-2021)
Europe Plecanatide Sales Forecast (2018-2021)
Japan Constipation Patient Population Forecast (2016-2021)
Japan Amitiza Sales Forecast (2016-2021)
China Constipation Patient Population Forecast (2016-2021)
China Amitiza Sales Forecast (2018-2021)
Global Ageing Population (2012-2016)
Global Healthcare Expenditure per Capita (2012-2016)
Global Spending on Medicines (2012-2016)
Global Spinal Cord Injury Patient Population (2012-2016)
Global Pharmaceutical R&D Spending (2013-2016)
Revenue Comparison of Key Players (2016)
Market Cap of Key Players (2016)
The U.S. Constipation Market Share by Company (2016)
The U.S. Constipation Market Share Forecast by Company (2021)
Ironwood Pharmaceuticals Inc Revenue by Product (2016)
Ironwood Pharmaceutical Inc. Revenue and Net Loss (2012-2016)
Ironwood Pharmaceuticals Inc. R&D Expenditure (2014-2016)
Sucampo Pharmaceuticals Inc. Revenue by Product (2016)
Sucampo Pharmaceuticals Inc. Revenue and Net Income (2012-2016)
Sucampo Pharmaceuticals Inc. R&D Expenditure (2014-2016)
ARDELYX, Inc. Total Revenue and Net Loss (2012-2016)
ARDELYX, Inc. R&D Expenditure (2014-2016)
Synergy Pharmaceuticals, Inc. Net Loss (2012-2016)
Synergy Pharmaceuticals, Inc. R&D Expenditure (2014-2016)
Types of Constipation
Current Treatment Options for Constipation
The U.S. Constipation Market by Value (2012-2016)
The U.S. Constipation Market by Type (2012-2016)
The U.S. Constipation Market Forecast by Value (2017-2021)
The U.S. Constipation Market Forecast by Type (2017-2021)
The U.S. Constipation Market by Drug (2016/2021)
The U.S. Constipation Branded Drugs Prescription Volume (2012-2016)
The U.S. Constipation Branded Drug Prescription Volume by Type (2012-2016)
The U.S. Constipation Patient Population Forecast (2016-2021)
Europe CIC Patient Population Forecast (2016-2021)
Europe IBS-C Patient Population Forecast (2016-2021)
Europe OIC Patient Population Forecast (2016-2021)
Europe Plecanatide Sales Forecast (2018-2021)
Japan Constipation Patient Population Forecast (2016-2021)
Japan Amitiza Sales Forecast (2016-2021)
China Constipation Patient Population Forecast (2016-2021)
China Amitiza Sales Forecast (2018-2021)
Global Ageing Population (2012-2016)
Global Healthcare Expenditure per Capita (2012-2016)
Global Spending on Medicines (2012-2016)
Global Spinal Cord Injury Patient Population (2012-2016)
Global Pharmaceutical R&D Spending (2013-2016)
Revenue Comparison of Key Players (2016)
Market Cap of Key Players (2016)
The U.S. Constipation Market Share by Company (2016)
The U.S. Constipation Market Share Forecast by Company (2021)
Ironwood Pharmaceuticals Inc Revenue by Product (2016)
Ironwood Pharmaceutical Inc. Revenue and Net Loss (2012-2016)
Ironwood Pharmaceuticals Inc. R&D Expenditure (2014-2016)
Sucampo Pharmaceuticals Inc. Revenue by Product (2016)
Sucampo Pharmaceuticals Inc. Revenue and Net Income (2012-2016)
Sucampo Pharmaceuticals Inc. R&D Expenditure (2014-2016)
ARDELYX, Inc. Total Revenue and Net Loss (2012-2016)
ARDELYX, Inc. R&D Expenditure (2014-2016)
Synergy Pharmaceuticals, Inc. Net Loss (2012-2016)
Synergy Pharmaceuticals, Inc. R&D Expenditure (2014-2016)
LIST OF TABLES
Drugs under Development for Constipation (2016)
ARDELYX, Inc. Drugs Under Pipeline
Synergy Pharmaceuticals, Inc. Drugs Under Pipeline (2016)
Drugs under Development for Constipation (2016)
ARDELYX, Inc. Drugs Under Pipeline
Synergy Pharmaceuticals, Inc. Drugs Under Pipeline (2016)
